A compassionate use case — a regulatory pathway for experimental medications — has drawn unusual public notice, according to Ars Technica. Speculation suggests the seventy-nine-year-old patient in question may be a former U.S. president being treated with an experimental obesity drug. While compassionate use cases are typically private, the public attention to this particular case is what struck reporting as remarkable.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton